Overall, these results suggest that overexpression of SPARC contributes to the repair of transient membrane glands and cuprocytes, proliferation of corneal epithelial cells, and inhibition of inflammatory response, thereby promoting the efficacy of ADMSC in treating dry eye syndrome. This evidence concerns the gene SPARC and dry eye syndrome.